The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision
Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy
The product basket increased to 1800 medicines and 285 Surgical Equipment
Unfortunate to see PM’s ‘Make in India’ dream being bulldozed
Take proper precautions and seek timely treatment!
The company has reported total income of Rs. 6738.4 crores during the period ended June 30, 2023
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1185.39 crores during the period ended June 30, 2023
Dr. Lal Path Labs Ltd. has reported total income of Rs. 555.4 crores during the period ended June 30, 2023
The company has reported total income of Rs. 1052.79 crores during the period ended June 30, 2023
Subscribe To Our Newsletter & Stay Updated
